SMTL ID : 4wlb.3 (3 other biounits)

Crystal structure of RORc in complex with a partial inverse agonist compound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x SER- LEU- LEU- LYS- LYS- LEU- LEU- ASP: SRC-1 peptide(Non-covalent)

SER-LEU-LEU-LYS-LYS-LEU-LEU-ASP.1: 11 residues within 4Å: Chain A: K.91, M.97, Q.101, Q.104, I.105, L.108, K.109, P.255, L.256, E.259, L.260 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:K.91, A:Q.104, A:I.105, A:L.108, A:P.255, A:L.256, A:L.256, A:L.260 Hydrogen bonds: A:Q.101, A:Q.101, A:E.259, A:E.259 Water bridges: A:K.91

1 x 3QQ: N-(4-fluorobenzyl)-N-(2-methylpropyl)-6-{[1-(methylsulfonyl)piperidin-4-yl]amino}pyridine-3-sulfonamide(Non-covalent)

3QQ.2: 20 residues within 4Å: Chain A: C.40, Q.41, L.42, L.47, W.72, C.75, H.78, L.79, M.113, R.119, M.120, R.122, A.123, F.133, F.143, L.146, L.151, I.152, I.155, H.234 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.42, A:H.78, A:L.79, A:A.123, A:L.146, A:I.152, A:I.155, A:I.155 Hydrogen bonds: A:L.42, A:R.122 Water bridges: A:Q.41

2 x TLA: L(+)-TARTARIC ACID(Non-covalent)

TLA.3: 2 residues within 4Å: Chain A: R.49, N.53 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.49, A:N.53 Salt bridges: A:R.49 TLA.4: 7 residues within 4Å: Chain A: R.51, Y.124, N.125, A.126, D.127, S.163, H.166 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:A.126, A:D.127, A:D.127, A:S.163 Water bridges: A:R.51, A:R.51, A:R.51 Salt bridges: A:R.51

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

van Niel, M.B. et al., A reversed sulfonamide series of selective RORc inverse agonists. Bioorg.Med.Chem.Lett. (2014)

Release Date

2014-11-12

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence